Fast-Acting Pill Lowers Heartburn Regularity in Non-Erosive Reflux Condition

Clients with non-erosive reflux condition (GEEK) that took once-daily tegoprazan– a novel, fast-acting, oral potassium-competitive acid blocker (P-CAB)– had a considerable reduction in heartburn frequency, a stage III test revealed.

Amongst patients randomized to placebo or tegoprazan 50 mg or 100 mg, indicate percents of 24 hour heartburn‑free days through week 4 were 17 3 %, 26 2 %, and 30 1 %, respectively, equating into loved one enhancements of 51 % ( P =0. 0006 and 74 % ( P